In-vivo selection of an azole-resistant petite mutant of Candida glabrata.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 11073151)

Published in J Med Microbiol on November 01, 2000

Authors

J P Bouchara1, R Zouhair, S Le Boudouil, G Renier, R Filmon, D Chabasse, J N Hallet, A Defontaine

Author Affiliations

1: Groupe d'Etude des Interactions Hôte-Parasite, Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire, Angers, France. Jean-Philippe.Bouchara@univ-angers.fr

Articles citing this

Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Chemother (2001) 2.14

Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes. PLoS Pathog (2014) 1.98

Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog (2009) 1.76

Mechanisms of azole resistance in petite mutants of Candida glabrata. Antimicrob Agents Chemother (2004) 1.37

Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi. Microbiology (2008) 1.28

Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy. Eukaryot Cell (2011) 1.22

Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother (2011) 1.21

Multidrug resistance in fungi. Eukaryot Cell (2007) 1.20

Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata. PLoS Pathog (2012) 1.10

A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole. Antimicrob Agents Chemother (2007) 1.06

Relationships between respiration and susceptibility to azole antifungals in Candida glabrata. Antimicrob Agents Chemother (2003) 1.06

The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. Virulence (2012) 1.03

Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants. Antimicrob Agents Chemother (2012) 1.01

A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata. Antimicrob Agents Chemother (2008) 1.00

Multidrug resistance in fungi: regulation of transporter-encoding gene expression. Front Physiol (2014) 0.98

Mitochondria influence CDR1 efflux pump activity, Hog1-mediated oxidative stress pathway, iron homeostasis, and ergosterol levels in Candida albicans. Antimicrob Agents Chemother (2013) 0.96

Phenotypic switching in Candida lusitaniae on copper sulfate indicator agar: association with amphotericin B resistance and filamentation. J Clin Microbiol (2006) 0.94

Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth. Antimicrob Agents Chemother (2009) 0.84

Mutants with heteroresistance to amphotericin B and fluconazole in Candida. Braz J Microbiol (2009) 0.81

Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata. Front Cell Infect Microbiol (2013) 0.79

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species. Front Microbiol (2017) 0.75

Articles by these authors

Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis (2000) 2.17

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care (1998) 1.59

Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. J Clin Endocrinol Metab (1999) 1.58

[Cutaneous ulcer from Mycobacterium ulcerans. Apropos of 1 case in French Guiana]. Bull Soc Pathol Exot (1992) 1.42

Viral antigens in osteoclasts from Paget's disease of bone. Lancet (1980) 1.34

Chronic airway colonization by Penicillium emersonii in a patient with cystic fibrosis. Med Mycol (1999) 1.28

The search for virulence determinants in Aspergillus fumigatus. Trends Microbiol (1995) 1.25

In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. J Med Microbiol (1999) 1.23

Interaction between Aspergillus fumigatus and basement membrane laminin: binding and substrate degradation. Biol Cell (1993) 1.22

Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion. Infect Immun (1994) 1.22

A rapid miniprep method for the preparation of yeast mitochondrial DNA. Nucleic Acids Res (1991) 1.18

Sialic acid-dependent recognition of laminin and fibrinogen by Aspergillus fumigatus conidia. Infect Immun (1997) 1.18

Genes and enzymes of the acetyl cycle of arginine biosynthesis in Corynebacterium glutamicum: enzyme evolution in the early steps of the arginine pathway. Microbiology (1996) 1.17

Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia. Infect Immun (1997) 1.16

The highly thermostable arginine repressor of Bacillus stearothermophilus: gene cloning and repressor-operator interactions. Mol Microbiol (1997) 1.13

Towards a viral etiology for Paget's disease of bone. Metab Bone Dis Relat Res (1981) 1.13

Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia. Infect Immun (1992) 1.12

[Cercarial dermatitis in Europe: a new public health problem?]. Bull World Health Organ (1996) 1.12

Influence of fluoride, hydrogen peroxide and lactic acid on the corrosion resistance of commercially pure titanium. Acta Biomater (2005) 1.10

Bone tissue in Paget's disease of bone. Ultrastructure and Immunocytology. Arthritis Rheum (1980) 1.04

Paramyxovirus antigens in osteoclasts from Paget's bone tissue detected by monoclonal antibodies. J Gen Virol (1985) 1.04

Cell surface properties of Aspergillus fumigatus conidia: correlation between adherence, agglutination, and rearrangements of the cell wall. Can J Microbiol (1995) 1.04

Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs. Diabetes (2001) 1.02

Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components. Eur J Cell Biol (1996) 1.00

Molecular epidemiology of airway colonisation by Aspergillus fumigatus in cystic fibrosis patients. J Med Microbiol (2001) 1.00

Antiatherogenic properties of metformin: the experimental evidence. Diabetes Metab (2003) 0.99

Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them? Clin Rev Allergy Immunol (2008) 0.98

Association of a myosin immunoanalogue with cell envelopes of Aspergillus fumigatus conidia and its participation in swelling and germination. Infect Immun (1999) 0.98

Purification and characterization of a fibrinogenolytic serine proteinase from Aspergillus fumigatus culture filtrate. FEBS Lett (1992) 0.96

Extracellular fibrinogenolytic enzyme of Aspergillus fumigatus: substrate-dependent variations in the proteinase synthesis and characterization of the enzyme. FEMS Immunol Med Microbiol (1993) 0.95

Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin Exp Immunol (2001) 0.95

Binding of fibrinogen to the pathogenic Aspergillus species. J Med Vet Mycol (1988) 0.94

First report of Cryptococcus albidus septicaemia in an HIV patient. J Infect (1996) 0.94

Cloning and expression of a beta-glycosidase gene from Thermus thermophilus. Sequence and biochemical characterization of the encoded enzyme. Glycoconj J (1999) 0.92

Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J Leukoc Biol (2004) 0.91

Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors. Diabetes (2000) 0.91

Genetic diversity and geographical distribution of wild Saccharomyces cerevisiae strains from the wine-producing area of Charentes, France. Appl Environ Microbiol (1995) 0.90

Silicon nephropathy and myeloperoxidase antibodies. Ann Rheum Dis (1994) 0.88

Mutational analysis of the thermostable arginine repressor from Bacillus stearothermophilus: dissecting residues involved in DNA binding properties. J Mol Biol (1999) 0.88

Ultrastructural characteristics of osteoclasts in Paget's disease. Rev Rhum Mal Osteoartic (1974) 0.88

Bacterial production and purification of recombinant human prolactin. Biotechnol Appl Biochem (1990) 0.88

Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes. Diabetes Obes Metab (2004) 0.87

Prognosis of vasculitis associated myelodysplasia. Autoimmun Rev (2013) 0.87

Typing of Scedosporium apiospermum by multilocus enzyme electrophoresis and random amplification of polymorphic DNA. J Med Microbiol (2001) 0.87

Development of 5-iodo-2'-deoxyuridine milling process to reduce initial burst release from PLGA microparticles. Int J Pharm (1999) 0.86

Osteoclastic resorption of Ca-P biomaterials implanted in rabbit bone. Calcif Tissue Int (1993) 0.86

A 33 kDa serine proteinase from Scedosporium apiospermum. Biochem J (1996) 0.85

[Mechanisms and implications of the adhesion phenomenon in Aspergillus fumigatus]. Pathol Biol (Paris) (1994) 0.84

[Dynamic study of anti-HIV antibody avidity after cellular immunity restoration under antiretroviral treatment]. Ann Biol Clin (Paris) (2001) 0.84

Anti-myeloperoxidase antibodies and associated diseases. Adv Exp Med Biol (1993) 0.84

The arginine operon of Bacillus stearothermophilus: characterization of the control region and its interaction with the heterologous B. subtilis arginine repressor. Mol Gen Genet (1996) 0.84

Candida ciferrii: clinical and microbiological features of an emerging pathogen. Mycoses (1992) 0.84

Immune restoration under HAART in patients chronically infected with HIV-1: diversity of T, B, and NK immune responses. Viral Immunol (2006) 0.83

Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2000) 0.83

Synthetic genes specifying periodic polymers modelled on the repetitive domain of wheat gliadins: conception and expression. Biochem Biophys Res Commun (1997) 0.83

[Malarial indices in 938 children and adolescents in the humid savanna area of the south of Mali]. Bull Soc Pathol Exot Filiales (1981) 0.83

[Pulmonary mycoses and parasitosis]. Ann Biol Clin (Paris) (1990) 0.82

[Evaluation of the health status of nomadic and semi-nomadic populations of the Gourma-Mali: epidemiologic approach. II. Overall results and conclusions]. Med Trop (Mars) (1983) 0.82

[Palindromic rheumatism. Immunologic survey and study of development in 43 cases]. Rev Rhum Mal Osteoartic (1987) 0.82

Biodegradability of poly (2-hydroxyethyl methacrylate) in the presence of the J774.2 macrophage cell line. Biomaterials (2004) 0.82

Evaluation of five commercial Sabouraud gentamicin-chloramphenicol agar media. Eur J Clin Microbiol Infect Dis (2001) 0.82

Oligonucleotide quartz crystal microbalance sensor for the microalgae Alexandrium minutum (Dinophyceae). Biosens Bioelectron (2005) 0.81

[Cutaneous alternariosis revealing Cushing's disease. A case with ultrastructural study]. Ann Dermatol Venereol (1982) 0.81

[Developmental bilharziasis caused by Schistosoma mansoni discovered 37 years after infestation]. Bull Soc Pathol Exot Filiales (1985) 0.81

[Osteoclastic inclusions in Paget's disease of bone]. Rev Rhum Mal Osteoartic (1975) 0.80

[Candida albicans chlamydospores observed in vivo in a patient with AIDS]. Ann Biol Clin (Paris) (1988) 0.80

Aspergillus terreus in a cystic fibrosis clinic: environmental distribution and patient colonization pattern. J Hosp Infect (2003) 0.80

Synthesis of methacryloyloxyethyl phosphate copolymers and in vitro calcification capacity. Biomaterials (2004) 0.80

Lipoprotein lipase enhances human monocyte adhesion to aortic endothelial cells. J Lipid Res (1997) 0.80

1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line. J Neurosci Res (1996) 0.80

[Demonstration of measles virus antigens in osteoclasts in Paget's disease of bone]. C R Seances Acad Sci D (1979) 0.80

Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary. Horm Res (1985) 0.79

[Positive amebic immunofluorescence reaction during hepatic brucellosis]. Bull Soc Pathol Exot Filiales (1981) 0.79

Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression. Arterioscler Thromb Vasc Biol (2000) 0.79

Gliclazide decreases vascular smooth muscle cell dysfunction induced by cell-mediated oxidized low-density lipoprotein. Metabolism (2001) 0.78

[Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI]. Bull Assoc Anat (Nancy) (1994) 0.78

Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology. Clin Orthop Relat Res (1984) 0.78

Differentiation of human monocytes to monocyte-derived macrophages is associated with increased lipoprotein lipase-induced tumor necrosis factor-alpha expression and production: a process involving cell surface proteoglycans and protein kinase C. Arterioscler Thromb Vasc Biol (1999) 0.78

Epidemiologic approach to human toxocariasis in western France. Parasitol Res (1994) 0.78

[Cutaneous Scedosporium infection revealed by bullous-necrotic purpura]. Ann Dermatol Venereol (1998) 0.77

Evidence for the lectin nature of some dermatophyte haemagglutinins. Ann Inst Pasteur Microbiol (1988) 0.77

Transient hypoparathyroidism induced by synthetic human parathyroid hormone-(1-34) treatment. J Clin Endocrinol Metab (1987) 0.77

Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production. Diabetes (1998) 0.77

Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide. Diabetes Obes Metab (2004) 0.77

[Serum and secretory immunoglobulins A. Molecular and cellular aspects of their biosynthesis and function]. Ann Med Interne (Paris) (1989) 0.77

[Paget's bone disease. Preliminary serological study]. Pathol Biol (Paris) (1983) 0.76

Cobalt, chromium and nickel affect hydroxyapatite crystal growth in vitro. Acta Biomater (2009) 0.76

[Urticaria and parasites]. Allerg Immunol (Paris) (1999) 0.76

Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin. Diabetes Obes Metab (1999) 0.76

[Blood eosinophilia in Hodgkin's disease and radiation therapy (author's transl)]. Sem Hop (1981) 0.76

The in vivo calcification capacity of a copolymer, based on methacryloyloxyethyl phosphate, does not favor osteoconduction. J Biomed Mater Res A (2004) 0.76

C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema. J Allergy Clin Immunol (1996) 0.76

Trichophyton rubrum isolated from aids and human immunodeficiency virus-infected patients in São Paulo, Brazil: antifungal susceptibility and extracellular enzyme production. Chemotherapy (2005) 0.76